Wegovyworks on the GLP-1 pathway, a gut hormone released after eating: it slows stomach emptying so you feel full longer, dampens appetite and “food noise” in the brain, and helps regulate insulin and blood sugar — together reducing how much you eat. The part that differs by product is which receptors it touches and how long it lasts: Wegovy is the GLP-1 receptor only, a peptide analogue sharing about 94% of its sequence with human GLP-1, and a C18 fatty-diacid chain that binds albumin in the blood, which shields it from the enzyme (DPP-4) that clears natural GLP-1 within minutes, which is why it is dosed once weekly. The albumin trick is why one injection covers seven days: natural GLP-1 is destroyed in roughly two minutes, so the whole engineering problem was making the same signal survive.
Wegovy mechanism of action
What sets Wegovy apart from the other GLP-1 drugs
- Receptors
- the GLP-1 receptor only
- Where the molecule comes from
- a peptide analogue sharing about 94% of its sequence with human GLP-1
- Why it lasts as long as it does
- a C18 fatty-diacid chain that binds albumin in the blood, which shields it from the enzyme (DPP-4) that clears natural GLP-1 within minutes
- Half-life
- about one week
- Dosing
- once weekly
The albumin trick is why one injection covers seven days: natural GLP-1 is destroyed in roughly two minutes, so the whole engineering problem was making the same signal survive.
Wegovy works through the glucagon-like peptide-1 (GLP-1) pathway— a natural gut-hormone signaling system that regulates appetite, gastric emptying, and blood sugar. By mimicking the body's own GLP-1 hormone for extended periods (the natural version is degraded within minutes; Wegovy lasts days), the medication triggers a cascade of metabolic effects: slowed gastric emptying, increased insulin secretion in response to meals, decreased glucagon release, and central signaling to the brain indicating satiety.
The rest of how this class works — the gut-hormone pathway, what it does to appetite and gastric emptying, what it does not do, and why the mechanism drives the common side effects — is the same for every GLP-1 medication and is covered once, in depth, in how GLP-1 medications work.
Wegovy chemistry — what's actually in the pen
Wegovy contains semaglutide — a peptide analogue sharing about 94% of its sequence with human GLP-1. It activates the GLP-1 receptor only, and its duration comes from a C18 fatty-diacid chain that binds albumin in the blood, which shields it from the enzyme (DPP-4) that clears natural GLP-1 within minutes.
Formulated by Novo Nordisk to the FDA-approved specification. Check your own carton and Medication Guide for the exact presentation you were dispensed — pen, vial, or tablet — because it varies by strength and by product.
FAQ about how Wegovy works
What makes Wegovy different from the other GLP-1 drugs?
The albumin trick is why one injection covers seven days: natural GLP-1 is destroyed in roughly two minutes, so the whole engineering problem was making the same signal survive. It activates the GLP-1 receptor only, and is a peptide analogue sharing about 94% of its sequence with human GLP-1.
How long does Wegovy take to work?
Appetite reduction often begins within the first one to two weeks, but meaningful weight loss builds over months as the dose is titrated up. Because Wegovy is taken once weekly with a half-life of about one week, each dose change takes that much longer to show its full effect — which is why titration schedules are spaced the way they are. Blood-sugar effects, where the product is approved for diabetes, can appear sooner.
Does Wegovy keep working if I stop taking it?
No — Wegovy works only while the medication is in your system, and with a half-life of about one week it leaves on that timescale rather than instantly. Appetite and weight effects typically reverse after stopping, which is why treatment is generally long-term. Discuss any stop or pause with your prescriber first.
Why does Wegovy cause nausea?
The same mechanism that reduces appetite — slowed gastric emptying and gut-brain satiety signalling through the GLP-1 receptor only — also drives the most common GI side effects. Slow titration is designed to let your body adapt, and because Wegovy is dosed once weekly, the adaptation window follows that rhythm.
Does Wegovy work if you don’t have diabetes?
Yes — the appetite and weight effects of GLP-1 medications don’t depend on having diabetes. Several are FDA-approved specifically for weight management in people with obesity or overweight who don’t have diabetes. Whether a particular product is approved for weight loss versus diabetes depends on the brand, so eligibility is a conversation for your prescriber.
How long does Wegovy stay in your system (half-life)?
Wegovy has a half-life of about one week, and it is dosed once weekly. Half-life is not the same as how long the drug is fully gone: clearance generally takes several half-lives, so a medication that lasts a week per dose can take roughly a month to leave entirely, while a short-acting one is out within days. That gap matters for planning around surgery or pregnancy. For the exact figures that apply to your dose, check the product information or ask your prescriber or pharmacist.
Editorial summary based on published pharmacology. Always discuss with your prescriber. Full disclaimer.